Home ›
Organizations ›
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
CA · Medical Research · EIN 952138184
56
Executives Disclosed
$97.2M
Annual Revenue
$159.7M
Total Assets
2.8:1
Internal Pay Ratio
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL has 56 executives with disclosed compensation. The highest-paid executive, David I Meyer Phd (PRESIDENT & CEO), received peak total compensation of $792,045. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| David I Meyer Phd | PRESIDENT & CEO | $792K | $699K | 2016–2021 | 10.6x |
| Ricardo Azziz | EVP/OPERATIONS/STRATEGY/SCI. AFFAIRS | $670K | $670K | 2023–2023 | 8.9x |
| David Meyer | PRESIDENT & CEO | $662K | $662K | 2022–2023 | 8.8x |
| Keith Hoffman Phd | VP DEVELOPMENT | $471K | $471K | 2020–2021 | 6.3x |
| Ashraf Ibrahim | INVESTIGATOR | $469K | $469K | 2017–2023 | 6.2x |
| Jerome I Rotter Md | BOARD MEMBER/INVESTIGATOR | $437K | $381K | 2017–2021 | 5.8x |
| Richard Katzman | COO | $431K | $282K | 2018–2022 | 5.7x |
| Joaquin Madrenas Md | CSO | $420K | $253K | 2020–2022 | 5.6x |
| Jerome Rotter Md | DIRECTOR / INVESTIGATOR | $398K | $398K | 2016–2016 | 5.3x |
| Albert F Parlow Phd | INVESTIGATOR | $397K | $397K | 2018–2020 | 5.3x |
| Joachin Madrenas | VP & CSO | $376K | $376K | 2018–2018 | 5x |
| Wei Yan | INVESTIGATOR | $345K | $345K | 2022–2023 | 4.6x |
| Alexander Kramer | VP & CFO | $344K | $184K | 2020–2022 | 4.6x |
| Matthew Budoff Md | INVESTIGATOR | $338K | $304K | 2016–2023 | 4.5x |
| Ronald Swerdloff | INVESTIGATOR | $334K | $217K | 2016–2018 | 4.5x |
| Jody S Spillane | ADMINISTRATOR | $311K | $311K | 2020–2021 | 4.1x |
| Thomas P Plotts Mba | TREASURER/CONSULTANT | $310K | $0 | 2016–2021 | 4.1x |
| Keith B Hoffman Phd | ADMINISTRATOR | $309K | $309K | 2017–2018 | 4.1x |
| Michael R Yeaman Phd | INVESTIGATOR | $306K | $302K | 2018–2021 | 4.1x |
| Jody Spillane | SVP, PUBLIC AFFAIRS | $295K | $295K | 2022–2023 | 3.9x |
| James J Hansberry Mba | VP FINANCE & CONTROL | $286K | $286K | 2020–2020 | 3.8x |
| Albert Parlow | INVESTIGATOR | $282K | $282K | 2016–2017 | 3.8x |
| Susan Rubin | ADMINISTRATOR | $271K | $271K | 2016–2016 | 3.6x |
| Rosemary Madnick | VP, RESEARCH ADMINISTRATION | $267K | $267K | 2023–2023 | 3.6x |
| Lynda Polgreen | BOARD MEMBER/INVESTIGATOR | $251K | $251K | 2020–2021 | 3.3x |
| Christina Wang Md | INVESTIGATOR | $247K | $247K | 2016–2016 | 3.3x |
| Karen Mayo | VP, SUPPORT OPERATIONS | $245K | $245K | 2022–2023 | 3.3x |
| Chou Tsui-Fen | INVESTIGATOR | $244K | $244K | 2018–2018 | 3.3x |
| Paul Kuc Through 91517 | VP-FINANCE & CFO | $243K | $243K | 2018–2018 | 3.2x |
| Yan Wei | INVESTIGATOR | $235K | $235K | 2021–2021 | 3.1x |
| Michael Yeaman | INVESTIGATOR | $230K | $230K | 2022–2023 | 3.1x |
| Dr Jerome Rotter | BOARD MEMBER/INVESTIGATOR | $230K | $230K | 2022–2022 | 3.1x |
| Yan Q Xiong Md | INVESTIGATOR | $227K | $227K | 2021–2021 | 3x |
| James Hansberry | VP FINANCE & CONTROLLER | $225K | $225K | 2022–2022 | 3x |
| Alexander McQuilkin | ADMINISTRATOR | $223K | $223K | 2017–2018 | 3x |
| Love Collins Iii | VP DEVELOPMENT | $223K | $223K | 2017–2017 | 3x |
| James Hansberry Beg 91617 | VP-FINANCE & ACTING CFO | $222K | $222K | 2018–2018 | 3x |
| Ms Lynda Polgreen | BOARD MEMBER/INVESTIGATOR | $216K | $216K | 2023–2023 | 2.9x |
| Yan Xiong | INVESTIGATOR | $214K | $214K | 2023–2023 | 2.9x |
| Lisa Hancock | ADMINISTRATOR | $209K | $209K | 2016–2016 | 2.8x |
| John Munz | VP, HUMAN RESOURCES | $202K | $202K | 2023–2023 | 2.7x |
| Kevin Dawson Md | ADMINISTRATOR | $200K | $200K | 2016–2016 | 2.7x |
| Dr Lynda Polgreen | BOARD MEMBER/INVESTIGATOR | $197K | $197K | 2022–2022 | 2.6x |
| Patricia I Dickson Md | BOARD MEMBER/INVESTIGATOR | $196K | $196K | 2016–2018 | 2.6x |
| Dr Harry Rossiter | BOARD MEMBER/INVESTIGATOR | $173K | $173K | 2022–2023 | 2.3x |
| Harry Rossiter | BOARD MEMBER/INVESTIGATOR | $163K | $163K | 2020–2021 | 2.2x |
| Evangeline Ohning | ADMINISTRATOR | $139K | $0 | 2016–2016 | 1.8x |
| Eric S Daar Md | BOARD MEMBER/INVESTIGATOR | $137K | $0 | 2016–2018 | 1.8x |
| Michael Jones | SVP & CFO | $116K | $0 | 2023–2023 | 1.5x |
| Dr Eric Daar | BOARD MEMBER/INVESTIGATOR/VICE CHAIR | $108K | $0 | 2023–2023 | 1.4x |
| Lynne Smith Md | SECRETARY/INVESTIGATOR | $107K | $0 | 2016–2021 | 1.4x |
| Paul Kuc | VP-FINANCE & CFO | $100K | $0 | 2017–2017 | 1.3x |
| Dr Lynne Smith | SECRETARY/BOARD MEMBER/INVESTIGATOR | $94K | $0 | 2022–2023 | 1.3x |
| Adam J Jonas Md | DIRECTOR / INVESTIGATOR | $66K | $0 | 2016–2016 | 0.9x |
| Steve Nissen | BOARD MEMBER/CONSULTANT | $60K | $0 | 2021–2021 | 0.8x |
| Dr Delphine Lee | BOARD MEMBER/INVESTIGATOR | $20K | $0 | 2023–2023 | 0.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 15 | $288K | $452K | $3.2M |
| 2017 | 14 | $283K | $433K | $2.8M |
| 2018 | 17 | $294K | $422K | $4.4M |
| 2020 | 15 | $366K | $792K | $4.8M |
| 2021 | 17 | $350K | $699K | $4.9M |
| 2022 | 15 | $261K | $469K | $3.7M |
| 2023 | 17 | $330K | $670K | $4.3M |
Email Alerts
Get notified about LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.